Study title:
Hudson-M-M, Greenwald-C, Thompson-E, Wilimas-J, Marina-N, Fairclough- D, Kauffman-W, Bozeman-P, Mackert-P-W, Abromowitch-M, Jenkins-J, Boulden-T, Kun-L.
Department of Hematology-Oncology, St Jude Children's Research Hospital, PO Box 318, Memphis, TN 38101, United States.
Efficacy and toxicity of multiagent chemotherapy and low-dose involved- field radiotherapy in children and adolescents with Hodgkin's disease.
Journal of Clinical Oncology {J-CLIN-ONCOL}, 1993, Vol/Iss/Pg. 11/1 (100-108), ISSN: 0732-183X.Hudson-M-M, Greenwald-C, Thompson-E, Wilimas-J, Marina-N, Fairclough- D, Kauffman-W, Bozeman-P, Mackert-P-W, Abromowitch-M, Jenkins-J, Boulden-T, Kun-L.
Department of Hematology-Oncology, St Jude Children's Research Hospital, PO Box 318, Memphis...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|